Found 342 matching trials
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma PHASE2 This study aims to systematically evaluate the safety and efficacy of adali...
Show More Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Learn More & Join Trial
A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC) PHASE2 This is a phase II study to assess the efficacy, safety, and Health Related...
Show More Learn More & Join Trial
DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer PHASE1 This clinical trial tests how well dynamic contrast enhanced magnetic reson...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
A Multicenter Phase II Clinical Study of Neoadjuvant Use of Camrelizumab in Combination With Chemotherapy for Organ Preservation in Esophageal Cancer PHASE2 This is a multicenter phase II clinical study to explore the efficacy, safe...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer EARLY_PHASE1 Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with con...
Show More Location
Antwerp University Hospital (UZA)
Learn More & Join Trial
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy PHASE2 This study is being conducted in patients with newly diagnosed breast cance...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial